dematerialized notices in the testing phase – Release

dematerialized notices in the testing phase – Release
dematerialized notices in the testing phase – Release

The National Medicines Safety Agency (ANSM) announced on Wednesday December 18 that it was launching an experimentation phase during which the instructions for many pharmaceutical products will be digitized and viewable online.

Replace the paper of a medication leaflet with a QR code. This is what the National Medicines Safety Agency (ANSM) wants to put in place. But before this practice becomes widespread, these dematerialized notices will be subjected to a test, the ANSM announced this Wednesday, December 18, on the occasion of the launch of this experiment. The project will be launched on October 1, 2025, once the boxes have been modified and made available in pharmacies. This pilot phase of the project will last two years, during which the use of digital notices will be evaluated by representatives of patients, healthcare professionals and manufacturers.

108 “city” medications – delivered in pharmacies outside the hospital environment – ​​are concerned, including paracetamol, statins used to fight cholesterol or cardiovascular diseases, vaccines or even treatments used to reduce the acidity of the stomach. 475 treatments available exclusively at the hospital will also be integrated into this stage of the project. Manufacturers who voluntarily participate in this test must now “modify their medication boxes to add a QR code to the boxes in town” to access digital notices and “remove the paper notice for the hospital »informed the ANSM.

The dematerialization of notices must provide patients with “better information” medical since the digital notices hosted in the Public Medicines Database (BDPM) are updated regularly, underlines the medicine policeman. This development should also favor “better use of medicines” to the extent that the e-leaflets are accompanied by instructional videos that explain how to properly use the medication, the agency said.

This project is part of a reflection launched at the European level and in a logic of ecological responsibility. According to the Shift Project’s 2023 report on the carbon footprint of Health in , the carbon footprint of medicines is estimated between 23% and 36% of total emissions from the health sector in France. According to the ANSM, similar experiments have been carried out in hospitals in other member states of the European Union. The list of laboratories selected for the pilot phase will be published at the end of January 2025 at the latest.

Health
Canada

-

-

PREV Our dietary advice of the week. Good news for these end-of-year holidays: chocolate reduces the risk of diabetes
NEXT “There have been three deaths from ALS in Windsor. That’s when I said, “Enough!” »